NASDAQ · FTXH
First Trust Nasdaq Pharmaceuticals ETF
$44.24+$0.47 (+1.07%)
First Trust Nasdaq Pharmaceuticals ETF’s quoted price sits in the upper half of its reported 52-week range, 1.21% below the high.
Loading market information…
AMEX · GRN · USD
Stock price
Quote as of Oct 30, 2026, 06:51 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
iPath Series B Carbon ETN’s quoted price sits in the upper half of its reported 52-week range, 1.23% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
The iPath Series B Carbon ETNs are financial products designed to mirror the performance of the Barclays Global Carbon II TR USD Index. Their objective is to provide investors with exposure to carbon pricing, which is determined by futures contracts tied to carbon emission allowances originating from established schemes such as the EU Emissions Trading System (EU ETS) and the Clean Development Mechanism (CDM).
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 10:03 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
$44.24+$0.47 (+1.07%)
First Trust Nasdaq Pharmaceuticals ETF’s quoted price sits in the upper half of its reported 52-week range, 1.21% below the high.
$84.68-$1.34 (-1.56%)
First Trust Alerian U.S. NextGen Infrastructure ETF’s quoted price sits in the upper half of its reported 52-week range, 7.02% below the high.
$77.25-$2.99 (-3.73%)
Putnam Emerging Markets Ex-China ETF’s quoted price sits in the lower half of its reported 52-week range, 18.85% below the high.
$28.93+$0.05 (+0.19%)
Virtus Real Asset Income ETF’s quoted price sits in the upper half of its reported 52-week range, 1.3% below the high.
$40.00-$0.59 (-1.45%)
TrueShares Structured Outcome (April) ETF’s quoted price sits in the upper half of its reported 52-week range, 3.14% below the high.
$37.44$0.00 (0.0%)
Rayliant SMDAM Japan Equity ETF’s quoted price sits in the upper half of its reported 52-week range, 10.67% below the high.
$24.16+$0.01 (+0.06%)
Fidelity Real Estate Investment ETF’s quoted price sits in the upper half of its reported 52-week range, 8.13% below the high.
$12.38+$0.19 (+1.56%)
Direxion Daily Magnificent 7 Bear 1X ETF’s quoted price sits in the lower half of its reported 52-week range, 20.23% below the high.
